U.S. Point-of-Care Molecular Diagnostics Market Size, Share & Trends Analysis Report Test Location, By Application (Infectious Diseases, Oncology, Prenatal Testing), By Technology (PCR, Sequencing), By End-use, And Segment Forecasts, 2024 - 2030

Table of Contents

Chapter 1. Methodology and Scope
                   1.1. Market Segmentation & Scope
                   1.2. Segment Definitions
                       1.2.1. Test Location
                       1.2.2. Application Type
                       1.2.3. Technology
                       1.2.4. End-use
                       1.2.5. Estimates and forecasts timeline
                   1.3. Research Methodology
                   1.4. Information Procurement
                       1.4.1. Purchased database
                       1.4.2. GVR’s internal database
                       1.4.3. Secondary sources
                       1.4.4. Primary research
                       1.4.5. Details of primary research
                           1.4.5.1. Data for primary interviews in Asia Pacific
                   1.5. Information or Data Analysis
                       1.5.1. Data analysis models
                   1.6. Market Formulation & Validation
                   1.7. Model Details
                       1.7.1. Commodity flow analysis (Model 1)
                       1.7.2. Approach 1: Commodity flow approach
                       1.7.3. Volume price analysis (Model 2)
                       1.7.4. Approach 2: Volume price analysis
                   1.8. List of Secondary Sources
                   1.9. List of Primary Sources
                   1.10. Objectives
Chapter 2. Executive Summary
                   2.1. Market Outlook
                   2.2. Segment Outlook
                       2.2.1. Test location outlook
                       2.2.2. Application type outlook
                       2.2.3. Technology outlook
                       2.2.4. End use outlook
                   2.3. Competitive Insights
Chapter 3. U.S. Point-of-Care Molecular Diagnostics Market Variables, Trends & Scope
                   3.1. Market Lineage Outlook
                       3.1.1. Parent market outlook
                       3.1.2. Related/ancillary market outlook
                   3.2. Market Dynamics
                       3.2.1. Market driver analysis
                           3.2.1.1. Increase in geriatric population
                           3.2.1.2. Introduction of technologically advanced products
                           3.2.1.3. Increase in demand for point-of-care testing
                           3.2.1.4. Growing prevalence of target diseases
                       3.2.2. Market restraint analysis
                           3.2.2.1. Presence of ambiguous regulatory framework
                           3.2.2.2. High capital investment
                       3.2.3. Market opportunity analysis
                           3.2.3.1. Increasing demand for rapid testing solutions
                           3.2.3.2. Increase in incidence of infectious diseases and genetic disorders
                   3.3. U.S. Point-of-Care Molecular Diagnostics Market Analysis Tools
                       3.3.1. Industry Analysis - Porter’s
                           3.3.1.1. Supplier power
                           3.3.1.2. Buyer power
                           3.3.1.3. Substitution threat
                           3.3.1.4. Threat of new entrant
                           3.3.1.5. Competitive rivalry
                       3.3.2. PESTEL Analysis
                           3.3.2.1. Political landscape
                           3.3.2.2. Technological landscape
                           3.3.2.3. Economic landscape
                   3.4. U.S. Point-of-Care Molecular Diagnostics Market: Prevalence Data
Chapter 4. U.S. Point-of-Care Molecular Diagnostics Market: Test Location Estimates & Trend Analysis
                   4.1. U.S. Point-of-Care Molecular Diagnostics Market: Test Location Dashboard
                   4.2. U.S. Point-of-Care Molecular Diagnostics Market: Test Location Movement Analysis
                   4.3. U.S. Point-of-Care Molecular Diagnostics Market Estimates and Forecasts, By Test Location, Revenue 2018 - 2030 (USD Million) (Number of Tests Conducted)
                   4.4. OTC
                       4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                   4.5. POC
                       4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 5. U.S. Point-of-Care Molecular Diagnostics Market: Application Estimates & Trend Analysis
                   5.1. U.S. Point-of-Care Molecular Diagnostics Market: Application Dashboard
                   5.2. U.S. Point-of-Care Molecular Diagnostics Market: Application Movement Analysis
                   5.3. U.S. Point-of-Care Molecular Diagnostics Market Estimates and Forecasts, By Application, Revenue 2018 - 2030 (USD Million) (Number of Tests Conducted)
                   5.4. Infectious Diseases
                       5.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                   5.5. Oncology
                       5.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                   5.6. Hematology
                       5.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                   5.7. Prenatal Testing
                       5.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                   5.8. Endocrinology
                       5.8.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                   5.9. Other Applications
                       5.9.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 6. U.S. Point-of-Care Molecular Diagnostics Market: Technology Estimates & Trend Analysis
                   6.1. U.S. Point-of-Care Molecular Diagnostics Market: Technology Dashboard
                   6.2. U.S. Point-of-Care Molecular Diagnostics Market: Technology Movement Analysis
                   6.3. U.S. Point-of-Care Molecular Diagnostics Market Estimates and Forecasts, By Technology, Revenue 2018 - 2030 (USD Million) (Number of Tests Conducted)
                   6.4. Application PCR- based
                       6.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                   6.5. Genetic Sequencing-based
                       6.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                   6.6. Hybridization-based
                       6.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                   6.7. Microarray-based
                       6.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 7. U.S. Point-of-Care Molecular Diagnostics Market: End-use Estimates & Trend Analysis
                   7.1. U.S. Point-of-Care Molecular Diagnostics Market: End-use Dashboard
                   7.2. U.S. Point-of-Care Molecular Diagnostics Market: End-use Movement Analysis
                   7.3. U.S. Point-of-Care Molecular Diagnostics Market Estimates and Forecasts, By End-use, Revenue 2018 - 2030 (USD Million) (Number of Tests Conducted)
                   7.4. Decentralized Labs
                       7.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                   7.5. Hospitals
                       7.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                   7.6. Home-care
                       7.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                   7.7. Assisted Living Healthcare Facilities
                       7.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                   7.8. Other uses
                       7.8.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 8. Competitive Landscape
                   8.1. Recent Developments & Impact Analysis, By Key Market Participants
                   8.2. Company/Competition Categorization
                   8.3. Vendor Landscape
                       8.3.1. List of key distributors and channel partners
                       8.3.2. Key customers
                       8.3.3. Key company market share analysis, 2023
                       8.3.4. Abbott Laboratories
                           8.3.4.1. Company overview
                           8.3.4.2. Financial performance
                           8.3.4.3. Product benchmarking
                           8.3.4.4. Strategic initiatives
                       8.3.5. QIAGEN
                           8.3.5.1. Company overview
                           8.3.5.2. Financial performance
                           8.3.5.3. Product benchmarking
                           8.3.5.4. Strategic initiatives
                       8.3.6. Danaher
                           8.3.6.1. Company overview
                           8.3.6.2. Financial performance
                           8.3.6.3. Product benchmarking
                           8.3.6.4. Strategic initiatives
                       8.3.7. Thermo Fisher Scientific, Inc.
                           8.3.7.1. Company overview
                           8.3.7.2. Financial performance
                           8.3.7.3. Product benchmarking
                           8.3.7.4. Strategic initiatives
                       8.3.8. BD
                           8.3.8.1. Company overview
                           8.3.8.2. Financial performance
                           8.3.8.3. Product benchmarking
                           8.3.8.4. Strategic initiatives
                       8.3.9. F. Hoffman-La Roche AG
                           8.3.9.1. Company overview
                           8.3.9.2. Financial performance
                           8.3.9.3. Product benchmarking
                           8.3.9.4. Strategic initiatives
                       8.3.10. Charles River Laboratories
                           8.3.10.1. Company overview
                           8.3.10.2. Financial performance
                           8.3.10.3. Product benchmarking
                           8.3.10.4. Strategic initiatives
                       8.3.11. Quest Diagnostics Incorporated
                           8.3.11.1. Company overview
                           8.3.11.2. Financial performance
                           8.3.11.3. Product benchmarking
                           8.3.11.4. Strategic initiatives
                       8.3.12. Bio-Rad Laboratories, Inc.
                           8.3.12.1. Company overview
                           8.3.12.2. Financial performance
                           8.3.12.3. Product benchmarking
                           8.3.12.4. Strategic initiatives
                       8.3.13. Hologic Inc.
                           8.3.13.1. Company overview
                           8.3.13.2. Financial performance
                           8.3.13.3. Product benchmarking
                           8.3.13.4. Strategic initiatives
                       8.3.14. Agilent Technologies, Inc.
                           8.3.14.1. Company overview
                           8.3.14.2. Financial performance
                           8.3.14.3. Product benchmarking
                           8.3.14.4. Strategic initiatives

List of Tables

Table 1. List of abbreviation
Table 2. U.S. point-of-care molecular diagnostics market, by test location, 2018 - 2030 (USD Million) (Number of Tests Performed)
Table 3. U.S. point-of-care molecular diagnostics market, by application type, 2018 - 2030 (USD Million) (Number of Tests Performed)
Table 4. U.S. point-of-care molecular diagnostics market, by technology, 2018 - 2030 (USD Million) (Number of Tests Performed)
Table 5. U.S. point-of-care molecular diagnostics market, by end-use, 2018 - 2030 (USD Million) (Number of Tests Performed)

List of Figures

Fig. 1 U.S. point-of-care molecular diagnostics market segmentation
Fig. 2 Market research process
Fig. 3 Data triangulation techniques
Fig. 4 Primary research pattern
Fig. 5 Value chain based sizing & forecasting
Fig. 6 QFD modelling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Market snapshot
Fig. 9 Test location and end-use segment snapshot
Fig. 10 Application type and technology segment snapshot
Fig. 11 Competitive landscape snapshot
Fig. 12 Market dynamics
Fig. 13 Porter’s five forces analysis
Fig. 14 PESTLE analysis
Fig. 15 U.S. point-of-care molecular diagnostics market: Test location outlook and key takeaways
Fig. 16 U.S. point-of-care molecular diagnostics market: Test location movement analysis
Fig. 17 OTC market estimates and forecast, 2018 - 2030 (USD Million) (Number of Tests Performed)
Fig. 18 POC market estimates and forecast, 2018 - 2030 (USD Million) (Number of Tests Performed)
Fig. 19 U.S. point-of-care molecular diagnostics market: Application type outlook and key takeaways
Fig. 20 U.S. point-of-care molecular diagnostics market: Application type movement analysis
Fig. 21 Infectious Diseases market estimates and forecast, 2018 - 2030 (USD Million) (Number of Tests Performed)
Fig. 22 Oncology market estimates and forecast, 2018 - 2030 (USD Million) (Number of Tests Performed)
Fig. 23 Hematology market estimates and forecast, 2018 - 2030 (USD Million) (Number of Tests Performed)
Fig. 24 Prenatal testing market estimates and forecast, 2018 - 2030 (USD Million) (Number of Tests Performed)
Fig. 25 Endocrinology market estimates and forecast, 2018 - 2030 (USD Million) (Number of Tests Performed)
Fig. 26 Other applications market estimates and forecast, 2018 - 2030 (USD Million) (Number of Tests Performed)
Fig. 27 U.S. point-of-care molecular diagnostics market: Technology outlook and key takeaways
Fig. 28 U.S. point-of-care molecular diagnostics market: Technology movement analysis
Fig. 29 PCR-based market estimates and forecast, 2018 - 2030 (USD Million) (Number of Tests Performed)
Fig. 30 Genetic sequencing-based market estimates and forecast, 2018 - 2030 (USD Million) (Number of Tests Performed)
Fig. 31 Hybridization-based market estimates and forecast, 2018 - 2030 (USD Million) (Number of Tests Performed)
Fig. 32 Microarray-based market estimates and forecast, 2018 - 2030 (USD Million) (Number of Tests Performed)
Fig. 33 U.S. point-of-care molecular diagnostics market: End-use outlook and key takeaways
Fig. 34 U.S. point-of-care molecular diagnostics market: End-use movement analysis
Fig. 35 Decentralized labs market estimates and forecast, 2018 - 2030 (USD Million) (Number of Tests Performed)
Fig. 36 Hospitals market estimates and forecast, 2018 - 2030 (USD Million) (Number of Tests Performed)
Fig. 37 Home-care market estimates and forecast, 2018 - 2030 (USD Million) (Number of Tests Performed)
Fig. 38 Assisted Living Healthcare Facilities market estimates and forecast, 2018 - 2030 (USD Million) (Number of Tests Performed)
Fig. 39 Other uses market estimates and forecast, 2018 - 2030 (USD Million) (Number of Tests Performed)
Fig. 40 U.S. point-of-care molecular diagnostics market revenue, by state, 2023 & 2030 (USD Million) (Number of Tests Performed)
Fig. 41 Company market share analysis, 2023
Fig. 42 Strategic framework